Medicon Hellas S.A. (ATH:MEDIC)

Greece flag Greece · Delayed Price · Currency is EUR
2.540
+0.040 (1.60%)
At close: Dec 5, 2025
18.69%
Market Cap 11.23M
Revenue (ttm) 18.54M
Net Income (ttm) 1.90M
Shares Out 4.42M
EPS (ttm) 0.43
PE Ratio 6.05
Forward PE n/a
Dividend 0.13 (5.20%)
Ex-Dividend Date Jul 4, 2025
Volume 6,748
Average Volume 2,536
Open 2.480
Previous Close 2.500
Day's Range 2.480 - 2.570
52-Week Range 1.929 - 2.920
Beta 0.61
RSI 53.66
Earnings Date Apr 24, 2026

About Medicon Hellas

Medicon Hellas S.A. operates in the diagnostics industry. The company offers instruments, tests, and procedures for public and private hospitals, primary care centers, diagnostic centers, and private laboratories in Greece and internationally. The company distributes various analyzer system for chemistry, immunochemistry and hematology labs, intensive care units, and point-of-care systems. It also produces reagents for various analyzers, such as specific protein and hematology, as well as clinical chemistry reagents comprising control and calib... [Read more]

Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Founded 1988
Employees 157
Stock Exchange Athens Stock Exchange
Ticker Symbol MEDIC
Full Company Profile

Financial Performance

In 2024, Medicon Hellas's revenue was 18.12 million, an increase of 0.03% compared to the previous year's 18.12 million. Earnings were 1.37 million, an increase of 3.38%.

Financial Statements

News

There is no news available yet.